跳到正文

WALSH COLIN 内部人交易：近期 SEC Form 4 交易

过去 18 个月，WALSH COLIN（CIK 1866174）在 1 家公司共报告 54 笔 SEC Form 4 内部人交易（最近一笔 2026-08-28）。

日期公司身份类型股数市值
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事买入85,000$1.8M
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出700$15,449
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出447$9,776
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出1,332$29,344
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出200$4,410
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出1,556$34,325
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出3,402$74,912
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出988$21,766
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出480$10,344
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出100$2,211
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出753$16,543
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出672$14,797
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出6,970$153,549
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出400$8,808
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出1,180$25,771
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出1,040$22,932
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出300$6,252
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出443$9,649
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出200$4,410
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事买入2.0M$0
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出1,163$25,807
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出100$2,199
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出6,763$146,148
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出76,418$1.6M
2026-08-28Attovia Therapeutics, Inc. (ATTO)董事卖出200$4,420

来源：SEC Form 4 申报文件 · 截至 2026-08-28